-36.2%
IONQ vs GSK
+14.2%
-50.3%
-63.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +8.3% | +2.4% | +5.9% | +9.2% |
| 7D | +25.5% | +4.9% | +20.5% | +27.7% |
| 30D | -11.4% | +10.8% | -22.2% | -7.5% |
| 3M | -20.5% | -1.8% | -18.7% | -20.8% |
| 6M | -28.2% | +4.1% | -32.3% | -26.0% |
| YTD | -21.2% | +7.9% | -29.1% | -18.3% |
| All | -36.2% | +14.2% | -50.3% | -33.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling